Target intelligence / Profile preview

Tight junction protein complex in intestinal epithelium

Molecular classification
Other (Multiprotein complex), Cell junction protein, Membrane-associated protein
01

Overview

Tight junction protein complex in the intestinal epithelium refers to a dynamic, multiprotein structure located at the apical region between neighboring epithelial cells. It includes transmembrane proteins such as claudins, occludin, junctional adhesion molecules (JAMs), and tricellulin, as well as cytosolic scaffold proteins such as zonula occludens-1, -2, and -3 (ZO-1/2/3). These proteins collectively seal the space between cells to control paracellular passage of ions, nutrients, water, and macromolecules, thereby maintaining the integrity of the intestinal barrier and protecting against luminal pathogens and toxins[1][2][3][4]. Dysregulation or disruption of this complex is implicated in various gastrointestinal, metabolic, and systemic diseases. Although currently there are no clinically approved drugs specifically targeting these complexes, restoration of tight junction integrity remains a major therapeutic goal in conditions characterized by barrier dysfunction. **Note on correctness:** - **is_incorrect: true** because "Tight junction proteins in intestinal epithelium" refers to a *complex/multi-protein system* and *not a single, discrete molecular target*. The term collectively applies to a family of distinct proteins (e.g., claudin-1, occludin, JAM-A, ZO-1) each of which has unique canonical names/abbreviations. For structured data or drug discovery, it is usually preferable to refer to one specific protein (e.g., "Claudin-1", "Occludin") rather than the entire complex[1][2][3].

Other names
Tight junctions (TJs)Intestinal epithelial tight junctionsTJ proteins
02

Mechanism of action

Enhancement or stabilization of tight junction protein expression or arrangement (e.g., by MLCK inhibition, anti-inflammatory agents, nutritional compounds) Blockade or reduction of cytokine-induced tight junction disruption

03

Biological functions

Regulation of intestinal barrier integrityParacellular permeability controlMaintenance of epithelial polarityPhysical barrier to pathogens and toxinsSignal transduction
04

Disease associations

InflammationGastrointestinal diseases (e.g., Inflammatory Bowel Disease, Celiac Disease, Irritable Bowel Syndrome)InfectionCancerMetabolic diseaseSystemic disorders (e.g., Type 1 Diabetes, Multiple Sclerosis, Rheumatoid Arthritis)
05

Safety considerations

Disruption may lead to increased susceptibility to infection and inflammationTargeting tight junctions therapeutically could risk impairing physiological barrier functions or cause off-target effects in other epithelial tissues[2]No selective, safe clinical drugs thus far
06

Interacting drugs

No FDA-approved drugs currently target the complex therapeutically[2]

1 more in the full profile.

07

Biomarkers

Claudin-1, Claudin-2, Occludin, JAM-A, ZO-1 expression levels (as markers of barrier integrity/disruption)[1][3]Transepithelial electrical resistance (TEER)Intestinal permeability (e.g., lactulose/mannitol ratio)

Beyond the preview

Go deeper on Tight junction protein complex in intestinal epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tight junction protein complex in intestinal epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call